{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:42:26Z","timestamp":1790854946300,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,4,5]],"date-time":"2011-04-05T00:00:00Z","timestamp":1301961600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12031-011-9516-4","type":"journal-article","created":{"date-parts":[[2011,4,4]],"date-time":"2011-04-04T12:57:53Z","timestamp":1301921873000},"page":"256-268","source":"Crossref","is-referenced-by-count":27,"title":["Modifications of p53 and the DNA Damage Response in Cells Expressing Mutant Form of the Protein Huntingtin"],"prefix":"10.1007","volume":"45","author":[{"given":"Jennifer L.","family":"Illuzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie A.","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B.","family":"Kmiec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,4,5]]},"reference":[{"key":"9516_CR1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.dnarep.2004.03.033","volume":"3","author":"M Ahn","year":"2004","unstructured":"Ahn M, Urist M, Prives C (2004) The Chk2 protein kinase. DNA Repair 3:1039\u20131047","journal-title":"DNA Repair"},{"key":"9516_CR2","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1046\/j.1432-1327.2001.02225.x","volume":"268","author":"E Appella","year":"2001","unstructured":"Appella E, Anderson CW (2001) Post-translational modifications and activation of p53 by genotoxic stresses. Eur J Biochem 268:2764\u20132772","journal-title":"Eur J Biochem"},{"key":"9516_CR3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2350-6-35","volume":"6","author":"L Arning","year":"2005","unstructured":"Arning L, Kraus PH, Saft C, Andrich J, Epplen JT (2005) Age of onset of Huntington disease is not modulated by the R72P variation in TP53 and the R196K variation in the gene coding for the human caspase activated DNase (hCAD). BMC Med Genet 6:35\u201337","journal-title":"BMC Med Genet"},{"key":"9516_CR4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499\u2013506","journal-title":"Nature"},{"key":"9516_CR5","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1126\/science.281.5383.1674","volume":"281","author":"S Banin","year":"1998","unstructured":"Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, Smorodinsky NI, Prives C, Reiss Y, Shiloh Y, Ziv Y (1998) Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 281:1674\u20131677","journal-title":"Science"},{"key":"9516_CR6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0955-0674(03)00003-6","volume":"15","author":"CL Brooks","year":"2003","unstructured":"Brooks CL, Gu W (2003) Ubiquitination, phosphorylation, and acetylation: the molecular basis of p53 regulation. Curr Opin Cell Biol 15:165\u2013171","journal-title":"Curr Opin Cell Biol"},{"key":"9516_CR7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.gde.2008.11.010","volume":"19","author":"S Carter","year":"2009","unstructured":"Carter S, Vousden KH (2009) Modifications of p53: competing for the lysines. Curr Opin Genet Development 19:18\u201324","journal-title":"Curr Opin Genet Development"},{"key":"9516_CR8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neulet.2004.10.018","volume":"2","author":"B Chattopadhyay","year":"2005","unstructured":"Chattopadhyay B, Baksi K, Mukhopadhyay S, Bhattacharyya NP (2005) Modulation of age of onset of Huntington\u2019s disease patients by variations in TP53 and human caspase activated DNase (hCAD) genes. Neurosci Lett 2:81\u201386","journal-title":"Neurosci Lett"},{"key":"9516_CR9","doi-asserted-by":"crossref","first-page":"13777","DOI":"10.1073\/pnas.96.24.13777","volume":"96","author":"NH Chehab","year":"1999","unstructured":"Chehab NH, Malikzay A, Stavridi ES, Halazonetis TD (1999) Phosphorylation of ser-20 mediates stabilization of human p53 in response to DNA damage. Proc Natl Acad Sci 96:13777\u201313782","journal-title":"Proc Natl Acad Sci"},{"key":"9516_CR10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.mcn.2005.05.003","volume":"30","author":"S Cong","year":"2005","unstructured":"Cong S, Pepers BA, Evert BO, Rubinsztein DC, Roos RA, van Ommen GJ, Dorsman JC (2005) Mutant huntingtin represses CBP, but not p300, by binding and protein degradation. Mol Cell Neurosci 30:12\u201323","journal-title":"Mol Cell Neurosci"},{"key":"9516_CR11","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","volume":"14","author":"M DiFiglia","year":"1995","unstructured":"DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, Young C, Martin E, Vonsattel JP, Carraway R, Reeves SA, Boyce FM, Aronin N (1995) Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14:1075\u20131081","journal-title":"Neuron"},{"key":"9516_CR12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ccr.2009.02.004","volume":"15","author":"CM Eischen","year":"2009","unstructured":"Eischen CM, Lozano G (2009) p53 and MDM2: antagonists or partners in crime? Cancer Cell Previews 15:161\u2013162","journal-title":"Cancer Cell Previews"},{"key":"9516_CR13","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1083\/jcb.200905138","volume":"189","author":"Y Enokido","year":"2010","unstructured":"Enokido Y, Tamura T, Ito H, Arumughan A, Komuro A, Shiwaku H, Sone M, Foulle R, Sawada H, Ishiguro H, Ono T, Murata M, Kanazawa I, Tomilin N, Tagawa K, Wanker EE, Okazawa H (2010) Mutant huntingtin impairs Ku70-mediated DNA repair. J Cell Biol 189:425\u2013443","journal-title":"J Cell Biol"},{"key":"9516_CR14","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S1097-2765(03)00359-9","volume":"12","author":"JM Espinosa","year":"2003","unstructured":"Espinosa JM, Verdun RE, Emerson BM (2003) p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 12:1015\u20131027","journal-title":"Mol Cell"},{"key":"9516_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1145\/1122501.1122502","volume":"25","author":"Z Feng","year":"2006","unstructured":"Feng Z, Jin S, Zupnick A, Hoh J, de Stanchina E, Lowe S, Prives C, Levine AJ (2006) p53 tumor suppressor protein regulates the levels of huntingtin gene expression. Oncogene 25:1\u20137","journal-title":"Oncogene"},{"key":"9516_CR16","doi-asserted-by":"crossref","first-page":"7288","DOI":"10.1128\/MCB.18.12.7288","volume":"18","author":"DA Freedman","year":"1998","unstructured":"Freedman DA, Levine AJ (1998) Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6. Mol Cell Biol 18:7288\u20137293","journal-title":"Mol Cell Biol"},{"key":"9516_CR17","first-page":"392","volume":"67","author":"JD Godin","year":"2010","unstructured":"Godin JD, Colombo K, Molina-Calavita M, Keryer G, Zala D, Charrin BC, Dietrich P, Volvert ML, Guillemot F, Dragatsis I, Bellaiche Y, Saudou F, Nguyen L, Humbert S (2010) Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis. Cell 67:392\u2013406","journal-title":"Cell"},{"key":"9516_CR18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","volume":"90","author":"W Gu","year":"1997","unstructured":"Gu W, Roeder RG (1997) Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90:595\u2013606","journal-title":"Cell"},{"key":"9516_CR19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1098\/rstb.1999.0446","volume":"354","author":"PS Harper","year":"1999","unstructured":"Harper PS (1999) Huntington\u2019s disease: a clinical, genetic, and molecular model for polyglutamine repeat disorders. Philos Trans R Soc Lond B Biol Sci 354:957\u2013961","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"9516_CR20","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1242\/jcs.115.5.941","volume":"115","author":"G Hoffner","year":"2002","unstructured":"Hoffner G, Kahlem P, Djian P (2002) Perinuclear localization of huntingtin as a consequence of its binding to microtubules through an interaction with B-tubulin: relevance to Huntington\u2019s disease. J Cell Sci 115:941\u2013948","journal-title":"J Cell Sci"},{"key":"9516_CR21","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0014-5793(97)01480-4","volume":"420","author":"R Honda","year":"1997","unstructured":"Honda R, Tanaka H, Yasuda H (1997) Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53. FEBS Lett 420:25\u201327","journal-title":"FEBS Lett"},{"key":"9516_CR22","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"Huntington\u2019s Disease Collaborative Research Group","year":"1993","unstructured":"Huntington\u2019s Disease Collaborative Research Group (1993) A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosome. Cell 72:971\u2013983","journal-title":"Cell"},{"key":"9516_CR23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jnr.21881","volume":"87","author":"J Illuzzi","year":"2009","unstructured":"Illuzzi J, Yerkes S, Parekh-Olmedo H, Kmiec EB (2009) DNA damage response proteins precede the appearance of visible mutant huntingtin aggregate. J Neurosci Res 87:733\u2013747","journal-title":"J Neurosci Res"},{"key":"9516_CR24","doi-asserted-by":"crossref","first-page":"5158","DOI":"10.1074\/jbc.M805696200","volume":"281","author":"Y Itahana","year":"2009","unstructured":"Itahana Y, Ke H, Zhang Y (2009) p53 oligomerization is essential for its C-terminal lysine acetylation. J Biol Chem 281:5158\u20135164","journal-title":"J Biol Chem"},{"key":"9516_CR25","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.nbd.2006.04.011","volume":"23","author":"H Jiang","year":"2006","unstructured":"Jiang H, Poirier MA, Liang Y, Pei Z, Wiskittel CE, Smith WW, DeFranco DB, Ross CA (2006) Depletion of CBP is directly linked with cellular toxicity caused by mutant huntingtin. Neurobiol Dis 23:543\u2013551","journal-title":"Neurobiol Dis"},{"key":"9516_CR26","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1074\/jbc.M505772200","volume":"281","author":"Y Kawaguchi","year":"2006","unstructured":"Kawaguchi Y, Ito A, Appella E, Yao T (2006) Charge modifications at multiple C-terminal lysine residues regulates p53 oligomerization and its nucleus-cytoplasm trafficking. J Biol Chem 281:1394\u20131400","journal-title":"J Biol Chem"},{"key":"9516_CR27","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1126\/science.2047879","volume":"252","author":"SE Kern","year":"1991","unstructured":"Kern SE, Kinzler KW, Bruskin A, Jarosz D, Friedman P, Prives C, Vogelstein B (1991) Identification of p53 as a sequence-specific DNA binding protein. Science 252:1708\u20131711","journal-title":"Science"},{"key":"9516_CR28","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1128\/MCB.22.5.1277-1287.2002","volume":"22","author":"SH Li","year":"2002","unstructured":"Li SH, Cheng AL, Zhou H, Lam S, Rao M, Li H, Li XJ (2002) Interaction of Huntington disease protein with the transcriptional activator Sp1. Mol Cell Biol 22:1277\u20131287","journal-title":"Mol Cell Biol"},{"key":"9516_CR29","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1126\/science.1091362","volume":"302","author":"M Li","year":"2003","unstructured":"Li M, Brooks CL, Wu-Baer F, Chen D, Baer R, Gu W (2003) Mono- versus polyubiquitination: differential control of p53 fate by MDM2. Science 302:1972\u20131975","journal-title":"Science"},{"key":"9516_CR30","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1128\/MCB.19.2.1202","volume":"19","author":"L Liu","year":"1999","unstructured":"Liu L, Scolnick D, Trievel R, Zhang H, Marmorstein R, Halazonetis T, Berger S (1999) p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage. Mol Cell Biol 19:1202\u20131209","journal-title":"Mol Cell Biol"},{"key":"9516_CR31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.stem.2008.11.006","volume":"4","author":"Y Liu","year":"2009","unstructured":"Liu Y, Elf SE, Miyata Y, Sashida G, Liu Y, Huang G, DiGiandomenico S, Lee JM, Deblasio A, Menendez S, Antipin J, Reva B, Koff A, Nimer SD (2009) p53 regulates hematopoietic stem cell quiescence. Cell Stem Cell 4:37\u201348","journal-title":"Cell Stem Cell"},{"key":"9516_CR32","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/sj.emboj.7601560","volume":"26","author":"N Marchenko","year":"2007","unstructured":"Marchenko N, Wolff S, Erster S, Becker K, Moll U (2007) Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J 26:923\u2013934","journal-title":"EMBO J"},{"key":"9516_CR33","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/sj.cdd.4401912","volume":"13","author":"J Marine","year":"2006","unstructured":"Marine J, Francoz S, Maetens M, Wahl G, Toledo F, Lozano G (2006) Keeping p53 in check: essential and synergistic functions of Mdm2 and Mdm4. Cell Death Differ 13:927\u2013934","journal-title":"Cell Death Differ"},{"key":"9516_CR34","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1242\/dev.02208","volume":"133","author":"K Meletis","year":"2006","unstructured":"Meletis K, Wirta V, Hede SM, Nister M, Lundeberg J, Frisen J (2006) p53 suppresses the self-renewal of adult neural stem cells. Development 133:363\u2013369","journal-title":"Development"},{"key":"9516_CR35","first-page":"724","volume":"9","author":"D Menendez","year":"2009","unstructured":"Menendez D, Inga A, Resnick MA (2009) The expanding universe of p53 targets. Nature 9:724\u2013737","journal-title":"Nature"},{"key":"9516_CR36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S1044-579X(02)00099-8","volume":"13","author":"D Michael","year":"2003","unstructured":"Michael D, Oren M (2003) The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 13:49\u201358","journal-title":"Semin Cancer Biol"},{"key":"9516_CR37","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.molcel.2004.10.016","volume":"16","author":"N Minksy","year":"2004","unstructured":"Minksy N, Oren M (2004) The RING domain of Mdm2 mediates histone ubiquitylation and transcriptional repression. Mol Cell 16:631\u2013639","journal-title":"Mol Cell"},{"key":"9516_CR38","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/0092-8674(92)90644-R","volume":"69","author":"J Momand","year":"1992","unstructured":"Momand J, Zambetti GP, Olson DC, George D, Levine AJ (1992) The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237\u20131245","journal-title":"Cell"},{"key":"9516_CR39","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/362857a0","volume":"362","author":"JD Oliner","year":"1993","unstructured":"Oliner JD, Pietenpol JA, Thiagalingam S, Gyuris J, Kinzler KW, Vogelstein B (1993) Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857\u2013860","journal-title":"Nature"},{"key":"9516_CR40","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1073\/pnas.91.6.1998","volume":"91","author":"JA Pietenpol","year":"1994","unstructured":"Pietenpol JA, Tokino T, Thaigalingam S, el-Diery WS, Kinzler KW, Vogelstein B (1994) Sequence-specific transcriptional activation is essential for growth suppression by p53. PNAS 91:1998\u20132002","journal-title":"PNAS"},{"key":"9516_CR41","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1476-5381.2009.00607.x","volume":"159","author":"I Pires","year":"2010","unstructured":"Pires I, Ward T, Dive C (2010) Oxaliplatin responses in colorectal cancer cells are modulated by CHK2 kinase inhibitors. Br J Pharmacol 159:1326\u20131338","journal-title":"Br J Pharmacol"},{"key":"9516_CR42","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/(SICI)1096-9896(199901)187:1<112::AID-PATH250>3.0.CO;2-3","volume":"187","author":"C Prives","year":"1999","unstructured":"Prives C, Hall PA (1999) The p53 pathway. J Pathol 187:112\u2013126","journal-title":"J Pathol"},{"key":"9516_CR43","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1006\/mcne.2001.1004","volume":"18","author":"S Rega","year":"2001","unstructured":"Rega S, Stiewe T, Chang DI, Pollmeir B, Esche H, Bardenheuer W, Marquitan G, Putzer BM (2001) Identification of the full-length huntingtin-interacting protein p231HBP\/HYBP as a DNA-binding factor. Mol Cell Neurosci 18:68\u201379","journal-title":"Mol Cell Neurosci"},{"key":"9516_CR44","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1074\/jbc.273.10.5858","volume":"273","author":"EP Rogakou","year":"1998","unstructured":"Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM (1998) DNA double-strand breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858\u20135868","journal-title":"J Biol Chem"},{"key":"9516_CR45","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1093\/emboj\/17.2.554","volume":"17","author":"J Roth","year":"1997","unstructured":"Roth J, Dobbelstein M, Freedman D, Shenk T, Levine AJ (1997) Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Eur Mol Biol Organization 17:554\u2013564","journal-title":"Eur Mol Biol Organization"},{"key":"9516_CR46","doi-asserted-by":"crossref","first-page":"2831","DOI":"10.1101\/gad.12.18.2831","volume":"12","author":"K Sakaguchi","year":"1998","unstructured":"Sakaguchi K, Herrera J, Saito S, Miki T, Bustin M, Vassilev A, Anderson C, Appella E (1998) DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12:2831\u20132841","journal-title":"Genes Dev"},{"key":"9516_CR47","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar A, Lindsey-Boltz LA, Unsal-Kacmaz K, Linn S (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39\u201385","journal-title":"Annu Rev Biochem"},{"key":"9516_CR48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.1092194","volume":"304","author":"JS Steffan","year":"2004","unstructured":"Steffan JS, Agrawal N, Pallos J, Rockabrand E, Trotman LC, Slepko N, Illes K, Lukacsovich T, Zhu YZ, Cattaneo E, Pandolfi PP, Thompson LM, Marsh JL (2004) SUMO modification of huntingtin and Huntington\u2019s disease pathology. Science 304:100\u2013104","journal-title":"Science"},{"key":"9516_CR49","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.1038\/sj.onc.1203130","volume":"18","author":"RV Sionov","year":"1999","unstructured":"Sionov RV, Haupt Y (1999) The cellular response to p53: the decision between life and death. Oncogene 18:6145\u20136157","journal-title":"Oncogene"},{"key":"9516_CR50","doi-asserted-by":"crossref","first-page":"11134","DOI":"10.1073\/pnas.96.20.11134","volume":"96","author":"GC Smith","year":"1999","unstructured":"Smith GC, Cary RB, Lakin ND, Hann BC, Teo SH, Chen DJ, Jackson SP (1999) Purification of DNA binding properties of ataxia\u2013telangiectasia gene product ATM. Proc Natl Acad Sci 96:11134\u201311139","journal-title":"Proc Natl Acad Sci"},{"key":"9516_CR51","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1073\/pnas.0702010104","volume":"104","author":"DP Teufel","year":"2007","unstructured":"Teufel DP, Freund SM, Bycroft M, Fersht AR (2007) Four domains of p300 each bind tightly to a sequence spanning both transactivation subdomains of p53. Proc Natl Acad Sci 104:7009\u20137014","journal-title":"Proc Natl Acad Sci"},{"key":"9516_CR52","doi-asserted-by":"crossref","first-page":"8195","DOI":"10.1128\/MCB.24.18.8195-8209.2004","volume":"24","author":"E Trushina","year":"2004","unstructured":"Trushina E, Dyer RB, Badger JDII, Ure D, Eide L, Tran DD, Vrieze BT, Legendre-Guillemin V, McPherson PS, Mandavilli BS, Van Houten B, Zeitlin S, McNiven M, Aebersold R, Hayden M, Parisi JE, Seeberg E, Dragatsis I, Doyle K, Bender A, Chacko C, McMurray CT (2004) Mutant huntingtin impairs axonal trafficking in mammalian neurons in vivo and in vitro. Mol Cell Biol 24:8195\u20138209","journal-title":"Mol Cell Biol"},{"key":"9516_CR53","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nrm2147","volume":"8","author":"KH Vousden","year":"2007","unstructured":"Vousden KH, Lane DP (2007) p53 in health and disease. Nat Rev Mol Cell Biol 8:275\u2013283","journal-title":"Nat Rev Mol Cell Biol"},{"key":"9516_CR54","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/sj.cdd.4401911","volume":"13","author":"GM Wahl","year":"2006","unstructured":"Wahl GM (2006) Mouse bites dogma: how mouse models are changing our views of how p53 is regulated in vivo. Cell Death Differ 13:973\u2013983","journal-title":"Cell Death Differ"},{"key":"9516_CR55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.sbi.2008.09.004","volume":"18","author":"L Wang","year":"2008","unstructured":"Wang L, Tang Y, Cole PA, Marmorstein R (2008) Structure and chemistry of the p300\/CBP and Rtt109 histone acetyltransferases: implications for histone acetyltranferase evolution and function. Curr Opin Struct Biology 18:741\u2013747","journal-title":"Curr Opin Struct Biology"},{"key":"9516_CR56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/542","volume":"19","author":"MJF Waterman","year":"1998","unstructured":"Waterman MJF, Stavridi ES, Waterman JLF, Halazonetis TD (1998) ATM-dependent activation of p53 involves dephosphorylation and association with 14-3-3 proteins. Nat Genet 19:175\u2013178","journal-title":"Nat Genet"},{"key":"9516_CR57","doi-asserted-by":"crossref","first-page":"5762","DOI":"10.1073\/pnas.0801353105","volume":"105","author":"M Wells","year":"2008","unstructured":"Wells M (2008) Structure of tumor suppressor p53 and its intrinsically disordered N-terminal transactivation domain. PNAS 105:5762\u20135767","journal-title":"PNAS"},{"key":"9516_CR58","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/emboj.2009.83","volume":"28","author":"S Wu","year":"2009","unstructured":"Wu S, Chiang C (2009) Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding. EMBO J 28:1246\u20131259","journal-title":"EMBO J"},{"key":"9516_CR59","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.cell.2005.10.030","volume":"123","author":"W Zhai","year":"2005","unstructured":"Zhai W, Jeong H, Cui L, Krainc D, Tjian R (2005) In vitro analysis of huntingtin-mediated transcriptional repression reveals multiple transcription factor targets. Cell 123:1241\u20131253","journal-title":"Cell"},{"key":"9516_CR60","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1126\/science.1058637","volume":"292","author":"Y Zhang","year":"2001","unstructured":"Zhang Y, Xiong Y (2001) A p53 amino-terminal nuclear export signal inhibited by DNA damage-induced phosphorylation. Science 292:1910\u20131915","journal-title":"Science"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9516-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-011-9516-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-011-9516-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T02:09:18Z","timestamp":1637460558000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-011-9516-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,4,5]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["9516"],"URL":"https:\/\/doi.org\/10.1007\/s12031-011-9516-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,4,5]]}}}